BRZE earnings analysis
What we found in BRZE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Braze delivered a strong quarterly beat, with revenue of $227.2 million, non-GAAP diluted EPS of $0.19 and free cash flow of $21.7 million, and management raised Q3 and full-year FY2027 outlook. Six-month revenue increased to $438.2 million from $342.2 million, while the six-month net loss narrowed to $43.8 million from $63.4 million. Offsetting positives are the unresolved ITGC material weakness, the $763.6 million accumulated deficit and continued reliance on non-GAAP profitability and cash resources.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue materially exceeded consensus
- Revenue was $227.2 million, $7.0 million above the $220.25 million consensus estimate. Six-month revenue was $438.2 million versus $342.2 million in the prior-year period, an increase of approximately 28.1%.
- Adjusted profitability beat estimates
- Non-GAAP diluted EPS was $0.19 versus the $0.08 consensus estimate, while non-GAAP operating income reached $22.0 million.
- Positive free cash flow
- Free cash flow was $21.7 million for the quarter, supporting liquidity despite continued GAAP losses.
- Strong liquidity position
- Cash, cash equivalents and marketable securities totaled $413.9 million as of July 31, 2026, including $243.1 million invested in government and corporate debt securities.
- Losses narrowed year over year
- The company reported a six-month net loss of $43.8 million, improving from a $63.4 million net loss in the prior-year period by $19.6 million, or approximately 30.9%.
- Control remediation is progressing
- Management expects to complete remediation of the IT general-controls weakness during the fiscal year ending January 31, 2027, although it stated that the timing cannot be guaranteed.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material weakness remains unresolved
- The company concluded that disclosure controls were ineffective as of July 31, 2026 because of one material weakness involving IT general controls over user access and program change management. Management stated that remediation may not be completed by January 31, 2027.
- Persistent losses and capital needs
- The company had an accumulated deficit of $763.6 million as of July 31, 2026 and recorded a six-month net loss of $43.8 million. Management also stated that it may require additional debt or equity financing if operating cash generation is insufficient, creating potential dilution or higher financing costs.
- Repurchase program reduces flexibility
- The company authorized a $100.0 million share-repurchase program and entered into a $50.0 million accelerated share-repurchase agreement, but no shares were delivered under the agreement during the three months ended July 31, 2026. Repurchases could reduce cash available for acquisitions or other strategic investments.
- Investment portfolio rate exposure
- A hypothetical 10% change in interest rates was not material to the consolidated financial statements, but $243.1 million of the company's $413.9 million liquidity portfolio was invested in government and corporate debt securities and remains exposed to changes in market values and interest income.
- Limited patent portfolio
- The company had 30 granted patents and one U.S. patent application pending as of July 31, 2026, leaving intellectual-property protection dependent on a relatively limited patent portfolio and continued enforceability of its rights.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.19
What they said about what is next.
Management raised Q3 FY2027 revenue guidance to $229.0 million-$230.0 million from $219.5 million-$220.5 million. FY2027 guidance is $910.0 million-$913.0 million of revenue and $0.64-$0.65 of non-GAAP diluted EPS.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 27, 2026
- Braze, Inc. reported solid Q1 results for FY27, with revenue of $211 million, exceeding consensus estimates and representing a 30% increase from the prior year. The company recorded a non-GAAP EPS of $0.10, reflecting…
- 10-K · March 25, 2026
- Braze positions itself as an AI-first, end-to-end customer engagement platform (BrazeAI, Canvas, Braze Data Platform) focused on real‑time, cross‑channel personalization. The company reported a Q4 revenue beat of…
- 10-Q · December 10, 2025
- Braze reported quarterly revenue of $190,842,000 for the three months ended October 31, 2025, up $38,790,000 or 25.5% versus $152,052,000 in the year-ago quarter. Gross margin compressed to 67.2% from 69.8% (a ~260 bp…
- 10-Q · September 5, 2025
- Braze reported quarterly revenue of $180,111,000 for the three months ended July 31, 2025, up $34,612,000 or 23.8% versus $145,499,000 in the prior-year quarter, but profitability weakened: gross margin fell to 67.7%…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing BRZE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever